Delivery Order SPE2DB20D3103-SPE2DB25FM6U7

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $97K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,711.37 firm-fixed-price contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a specialty medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,556.71, is for the delivery of RINVOQ ER 15 MG TABLET in quantities of 30 units. The contract has an ultimate completion date of April 13, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,092.28, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,156.58 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. It has an ultimate completion date of November 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,090.96, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. The contract has a completion date of November 14, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET medication. The delivery order, valued at $66,247.44, has a firm fixed price and an ultimate completion date of March 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,769.32, is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The contract type is Firm Fixed Price and the award date is January 29, 2025, with an ultimate completion date of January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of RINVOQ ER 30 MG TABLET UU 30S, a specialty medication. The fixed-price contract has a ceiling value of $22,655.01 and an ultimate completion date of November 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,212.92, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of February 13, 2023. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET in the amount of $15,194.85. The delivery order has a firm fixed price and an ultimate completion date of June 6, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM6U7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $97,380.02, is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The contract has a firm fixed price and an ultimate completion date of February 13, 2025. The contract is not designated as a set-aside.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/14/25, 10:17 AM